Intra-operative cisplatin for the treatment of canine extremity soft tissue sarcomas

Veterinary and Comparative Oncology

Volumn 7, Issue 2, 2009, Pages 122-129

  Havlicek, M ^a   Straw, R S ^b   Langova, V ^a   Dernell, W S ^c  

^a Veterinary Specialist Centre   (Australia)

^b Brisbane Veterinary Specialist Centre   (Australia)

^c Veterinary Dentistry and Oral Surgery   (United States)

Author keywords

Canine; Cisplatin; Extremity; Intra operative; Polymer; Sarcoma

Indexed keywords

CANIS FAMILIARIS;

EID: 65749096436     PISSN: 14765810     EISSN: 14765829     Source Type: Journal    
DOI: 10.1111/j.1476-5829.2008.00182.x     Document Type: Article

References (34)

1. Liptak JM and Forrest LJ. Soft tissue sarcomas. In: Small Animal Clinical Oncology, 4 th edn., SJ Withrow and EG MacEwen, eds., Philadelphia, WB Saunders, 2007:425-454.
2. Bostock DE and Dye MT. Prognosis after surgical excision of canine fibrous connective tissue sarcoma. Veterinary Pathology 1980; 17: 581-588.
3. Kuntz CA, Dernell WS, Powers BE, Dewitt C, Straw RC and Withrow SJ. Prognostic factors for surgical treatment of soft-tissue sarcomas in dogs: 75 cases (1986-1996). Journal of the American Veterinary Medical Association 1997; 211: 1147-1151.
4. Graves GM, Bjorling DE and Mahaffey E. Canine hemangiopericytoma: 23 cases (1967-1984). Journal of American Veterinary Medical Association 1988; 192: 99-102.
5. Postorino NC, Berg RJ, Powers BE, McChesney A, Taylor R and Withrow SJ. Prognostic variables for canine hemangiopericytoma: 50 cases (1979-1984). Journal of the American Animal Hospital Association 1988; 24: 501-509.
6. Dernell WS, Withrow SJ, Kuntz CA and Powers BE. Principles of treatment for soft tissue sarcoma. Clinical Techniques in Small Animal Practice 1998; 13: 59-64.
7. Banks TA, Straw RC and Thomson MET. Prospective study of canine soft tissue sarcoma treated by wide surgical excision: Quantitative evaluation of surgical margins. Australian Veterinary Journal 2004; 34: 158-163.
8. Bacon NJ, Dernell WS, Ehrhart N, Powers BE and Withrow SJ. Evaluation of primary re-excision after recent inadequate resection of soft tissue sarcomas in dogs: 41 cases (1999-2004). Journal of the American Veterinary Medical Association 2007; 230: 548-554.
9. Stefanello D, Morello E, Roccabianca P, Iussich S, Nassuato C, Martano M, Squassino CH, Avallone G, Romussi S and Buracco P. Marginal excision of low-grade spindle cell sarcoma of canine extremities: 35 dogs (1996-2006). Veterinary Surgery 2008; 37: 461-465.
10. Rassnick KM. Medical management of soft tissue sarcomas. Veterinary Clinics of North America 2003; 33: 517-531.
11. Schmidt RA, Conrad EU, Collins C, Rabinovitch P and Finney A. Measurement and prediction of the short-term response of soft tissue sarcomas to chemotherapy. Cancer 1993; 72: 2593-2601.
12. Selting KA, Powers BE, Thompson LJ, Mittleman E, Tyler JW, Lafferty MH and Withrow SJ. Outcome of dogs with high-grade soft tissue sarcomas treated with and without adjuvant doxorubicin chemotherapy: 39 cases (1996-2004). Journal of the American Veterinary Medical Association 2005; 227: 1442-1448.
13. Moore AS, Kirk C and Cardona A. Intracavitary cisplatin chemotherapy experience in six dogs. Journal of Veterinary Internal Medicine 1991; 5: 227-231.
14. Straw RC, Withrow SJ, Cooper MF, Powers BE, Douple EB, O'Brien MG, Jameson V, Lafferty M and Brekke JH. Cisplatin Delivered by D,L-Polylactic Acid: Studies with Canine Models, 1992, Poster presentation CU Medical Center 20 June 1992.
15. Straw RC, Withrow SJ, Douple EB, Brekke JH, Cooper MF, Schwarz PD, Greco DS and Powers BE. Effect of Cis-Diamminedichloroplatinum II released from D,L-Polylactic acid implanted adjacent to cortical allografts in dogs. Journal of Orthopaedic Research 1994; 12: 871-877.
16. Dunn RL, Yewey GL, Fujita SM, Josephs KR, Whitman SL, Southard GL, Dernell WS, Straw RC, Withrow SJ and Powers BE. Sustained release of cisplatin from an injectable implant delivery system. Journal of Bioactive and Compatible Polymers 1996; 11: 286-300.
17. Dernell WS, Withrow SJ, Straw RC, Powers BE, Drekke JH and Lafferty M. Intracavitary treatment of soft tissue sarcomas in dogs using cisplatin in a biodegradable polymer. Anticancer Research 1997; 17: 4499-4506.
18. Dernell WS, Straw RC, Withrow SJ, Powers BE, Fujita SM, Yewey GS, Joseph KF, Dunn RL, Whitman SL and Southard GL. Apparent interaction of dimethyl sulfoxide with cisplatin released from polymer delivery devices injected subcutaneously in dogs. Journal of Drug Targeting 1998; 5: 391-396.
19. Withrow SJ, Liptak JM, Straw RC, Dernell WS, Jameson VJ, Powers BE, Johnson JL, Brekke JH and Douple EB. Biodegradable cisplatin polymer in limb-sparing surgery for canine osteosarcoma. Annals of Surgical Oncology 2004; 11: 705-713.
20. Barabas K, Milner R, Lurie D and Adin C. Cisplatin: A review of toxicities and therapeutic applications. Veterinary and Comparative Oncology 2008; 6: 1-18.
21. Marconato L, Comastri S, Lorenzo MR, Abramo F and Bettini G. Postsurgical intra-incisional 5-fluorouracil in dogs with incompletely resected, extremity malignant spindle cell tumours: A pilot study. Veterinary and Comparative Oncology 2007; 5: 239-249.
22. Kitchell BE, Brown DM, Luck EE, Woods LL, Orenberg EK and Bloch DA. Intralesional implant for treatment of primary oral malignant melanoma in dogs. Journal of the American Veterinary Medical Association 1994; 204: 229-236.
23. Theon AP, Madewell BR, Ryu J and Castro J. Concurrent irradiation and intratumoural chemotherapy with cisplatin: A pilot study in dogs with spontaneous tumours. International Journal of Radiation Oncology, Biology, Physics 1994; 29: 1027-1034.
24. Theon AP, Pascoe JR and Meagher DM. Perioperative intratumoural administration of cisplatin for treatment of cutaneous tumours in equidae. Journal of the American Veterinary Medical Association 1994; 205: 1170-1176.
25. Splenehauer G, Veillard M and Benoit J-P. Formation and characterization of cisplatin loaded in poly(D,L-lactide) microspheres for chemoembolization. Journal of Pharmacological Sciences 1986; 75: 750-755.
26. Queensland Government (2006) http://www.deir.qld.gov.au/workplace/ publications/guides/cytotoxic/index.htm [accessed May 2006].
27. Coindre JM, Nguyen BB, Bochinon F, de Mascarel I and Trojani M. Histopathologic grading in spindle cell soft tissue sarcomas. Cancer 1988; 61: 2305-2309.
28. U.S. Food and Drug Administration (2002) Study AGL 9909 http://www.fda.gov/Cder/foi/%20label/2002/21379lbl.pdf [accessed September 2007].
29. Dernell WS, Withrow SJ, Straw RC and Lafferty M. Adjuvant chemotherapy using cisplatin by subcutaneous administration. Veterinary Cancer Society, 1994: 47-48, Abstract of the 14th Annual Conference, October 23-25, Townsend, Tennessee.
30. Leydon M and Sullivan J. Full thickness skin necrosis due to inadvertent interstitial infusion of cisplatin. Cancer Treatment Report 1983; 67: 199.
31. McChesney SL, Withrow SJ, Gillette EL, Powers BE and Dewhirst MW. Radiotherapy of soft tissue sarcomas in dogs. Journal of the American Veterinary Medical Association 1989; 194: 60-63.
32. McChesney Gillette SL, Dewhirst MW, Gillette EL, Thrall DE, Page RL, Powers BE, Withrow SJ, Rosner G, Wong C and Sim DA. Response of canine soft tissue sarcomas to radiation or radiation plus hyperthermia: A randomized phase II study. International Journal of Hyperthermia 1992; 8: 309-320.
33. McKnight JA, Mauldin GN, McEntee MC, Meleo KA and Patnaik AK. Radiation treatment for incompletely resected soft-tissue sarcomas in dogs. Journal of the American Animal Hospital Association 2000; 217: 205-210.
34. Forrest LJ, Chun R, Adams WM, Cooley AJ and Vail DM. Postoperative radiotherapy for canine soft tissue sarcoma. Journal of Veterinary Internal Medicine 2000; 14: 578-582.